BR100 Increased By (0.36%)
BR30 Decreased By (-0.13%)
KSE100 Increased By (0.22%)
KSE30 Increased By (0.37%)
AGHA 6.68 Increased By ▲ 0.01 (0.15%)
BECO 4.37 No Change ▼ 0.00 (0%)
BML 57.32 Increased By ▲ 0.88 (1.56%)
BOP 30.35 Increased By ▲ 0.01 (0.03%)
CNERGY 13.12 Increased By ▲ 0.03 (0.23%)
CSIL 5.41 Increased By ▲ 0.05 (0.93%)
FCCL 52.79 Increased By ▲ 0.41 (0.78%)
FFL 14.72 Decreased By ▼ -0.02 (-0.14%)
FNEL 1.12 No Change ▼ 0.00 (0%)
KEL 6.09 No Change ▼ 0.00 (0%)
KOSM 5.73 Increased By ▲ 0.77 (15.52%)
LOTCHEM 26.46 Decreased By ▼ -0.89 (-3.25%)
MLCF 93.16 Increased By ▲ 0.41 (0.44%)
NBP 164.66 Decreased By ▼ -0.32 (-0.19%)
NCPL 55.66 Increased By ▲ 0.02 (0.04%)
NPL 61.16 Decreased By ▼ -0.10 (-0.16%)
OGDC 316.73 Decreased By ▼ -1.03 (-0.32%)
PACE 9.87 Decreased By ▼ -0.06 (-0.6%)
PAEL 35.63 Increased By ▲ 0.13 (0.37%)
PIBTL 14.68 Increased By ▲ 0.11 (0.75%)
PPL 226.91 Decreased By ▼ -0.88 (-0.39%)
PRL 93.02 Increased By ▲ 0.45 (0.49%)
PTC 60.26 Decreased By ▼ -0.37 (-0.61%)
SSGC 23.81 Increased By ▲ 0.01 (0.04%)
TBL 8.75 Increased By ▲ 0.07 (0.81%)
TELE 7.80 Increased By ▲ 0.02 (0.26%)
TPL 22.35 Increased By ▲ 0.12 (0.54%)
TPLP 12.97 Increased By ▲ 0.30 (2.37%)
TREET 22.16 Decreased By ▼ -0.38 (-1.69%)
TRG 56.56 Decreased By ▼ -1.24 (-2.15%)
اردو
Android App
Print Edition Dollar to PKR
Daily Petrol Prices Intl Oil Prices Iran-US war Gold Rates Podcasts PSX Notices
Topic

Moderna's vaccine

Moderna files for full US approval of COVID-19 vaccine

Moderna files for full US approval of COVID-19 vaccine

Published 01 Jun, 2021 07:14pm
  • The development comes weeks after rival Pfizer Inc and its German partner BioNTech SE sought full approval for their COVID-19 vaccine in the United States.
  • Moderna said it will continue to submit data to the US Food and Drug Administration on a rolling basis over the coming weeks with a request for a priority review.
Moderna says its COVID-19 vaccine found safe, effective in teens

Moderna says its COVID-19 vaccine found safe, effective in teens

Published 25 May, 2021 05:33pm
  • Moderna Inc, whose vaccine is authorized for adults 18 and older, said it will submit the findings of its adolescent study to the US Food and Drug Administration and other regulators for emergency use authorization in early June.
  • US regulators took about a month to review a similar study from Pfizer/BioNtech, which was authorized for ages 12-15 on May 10. If Moderna gets the same treatment, its authorization would come in early July.
Japan health panel approves Moderna, AstraZeneca COVID-19 vaccines

Japan health panel approves Moderna, AstraZeneca COVID-19 vaccines

Published 20 May, 2021 07:37pm
  • The recommendations by a health ministry panel precede official approval by the government on Friday, national broadcaster NHK reported.
  • Supplies of the Moderna doses have already been imported and are planned for use at mass vaccination centres in Tokyo and Osaka from next week.
Moderna CEO says world faces 2022 COVID vaccine production surplus

Moderna CEO says world faces 2022 COVID vaccine production surplus

Published 23 Apr, 2021 05:58pm
  • "Next year there is going to be way too many vaccines for people on the planet," he said.
  • He added that Moderna was working hard to have a booster vaccine against COVID-19 variants approved by the northern hemisphere late summer or early autumn.
Israel says supplied first COVID-19 vaccines to Palestinians

Israel says supplied first COVID-19 vaccines to Palestinians

Published 01 Feb, 2021 08:54pm
  • The vaccines were transferred into the occupied West Bank and will be used by Palestinian Authority medical teams, according to a statement by COGAT.
  • Israel has earmarked an additional 3,000 doses for the Palestinians, said a COGAT spokesman.
Latest on worldwide spread of the coronavirus

Latest on worldwide spread of the coronavirus

Published 19 Jan, 2021 09:11pm
  • The European Union wants to set up a mechanism that would allow the sharing of surplus vaccines with poorer neighbouring states and Africa.
  • The EU's executive has warned this month that national plans so far for spending a record 1.8 trillion euros from the bloc's joint coffers were too poor to fly.
Loading...